1998 - PhD Bio-organic Chemistry, University of British Columbia
1992 - BSc (1st Hons) Chemistry/Microbiology, University of Victoria
Dr Mosi is a project manager with over 15 years’ experience in pharmaceutical drug research. She has developed and implemented novel assays for the purpose of the identification of inhibitors of metallo-enzymes as antibacterials, inhibitors of cysteine proteases for the treatment of cancer, and inhibitors of glucosidases for neurological diseases. Dr Mosi’s PhD studies involved the mechanism of reaction of two alpha glycosyltransferases, glycogen phosphorylase and cyclodextrin glycosyltransferase, through the use of modified substrates and inhibitors. Dr Mosi has applied expertise in enzymology, receptor based cell biology, drug metabolism and protein purification and production. As well, she has designed and standardized systems and procedures for interpreting scientific results. She also has a sound knowledge of FDA guidelines and is trained in GLP and GMP procedures. Dr Mosi is a past member of the Drug Information Association, International Society for the Study of Xenobiotics, Society for Biomolecular Screening, American Society of Microbiology, and the Canadian Society of Chemistry. She is the first author of 10 published, peer-reviewed manuscripts, and has edited numerous other papers in the fields of biology, biochemistry, enzymology, chemistry and pharmacology. Dr Mosi joined the Edanz Group as an editor in 2007.